NantHealth Continues Global Expansion of GPS Cancer™ by Bringing Advanced Genomic Profiling to Patients in Mexico
8 August 2017
NantHealth, Inc., a leading next-generation, evidence-based, personalized healthcare company, today announced that GPS Cancer, a molecular test that helps guide cancer treatment strategies includin
